CI_with has_Ingredient has_MoA has_PE may_prevent may_treat drug associated with AE in adult drug associated with AE in pediatric used to treat disease Glucocorticoid Receptor Agonists [MoA] Asthma [Disease/Finding] Drug Hypersensitivity [Disease/Finding] Nasal Polyps [Disease/Finding] Rhinitis, Allergic, Perennial [Disease/Finding] Skin Diseases, Infectious [Disease/Finding] Status Asthmaticus [Disease/Finding] fluticasone [Chemical/Ingredient] Decreased Glucocorticoid Secretion [PE] Decreased Lysosomal Function [PE] Decreased Protein Synthesis [PE] Decreased Polymorphonuclear Leukocyte Migration [PE] Decreased Fibroblast Migration [PE] Decreased Capillary Permeability [PE] F [Preparations] FLUTICASONE http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20549slr016,20548slr020,20121slr030_flonase_lbl.pdf 4020529 CUT2W21N7U C14834 Ingredient <VANDF_Record>50.416^3174^</VANDF_Record><VA_File>50.416</VA_File><VA_IEN>3174</VA_IEN> C0082607 fluticasone FLUTICASONE Active <VANDF_Record>50.6^2706^</VANDF_Record><VA_File>50.6</VA_File><VA_IEN>2706</VA_IEN> N0000148245 41126 nose disease pharyngitis AE headache AE cough AE asthma AE epistaxis AE nausea AE vomiting AE